CLINICAL_TRIALS
trial_result
· 2025-10-21
Clinical Trial Update: The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD [Phase 4]
Summary
Phase 4 trial evaluating BEVESPI AEROSPHERE (glycopyrrolate/formoterol fumarate) on exercise tolerance in chronic obstructive pulmonary disease has completed. R…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: William Stringer, md | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2025-10-21